Welcome to the eleventh issue of Health Technology Update. This second newsletter of 2009 brings you information on a variety of medical technologies.
The issue’s feature article addresses the current global crisis in isotope production in medical imaging. New and emerging technologies and practices are currently being identified that may play a role in providing alternative solutions to molybdenum- 99 , the medical isotope that is currently in short supply.
The solutions explored are those that could be adopted within a five to ten year time frame. We also bring you an update on the expanding distribution of positron emission tomography or PET scanners in Canada; PET imaging is one of several alternatives to isotope use.
Additionally, this issue provides a cross-section of emerging genetic tests, and we look at a group that supports the development and implementation of an evidence- based process for evaluating genomic applications.
In this Issue:
Future alternatives to molybdenum- 99 (Mo- 99 ) production for medical imaging
An exploration of the various alternatives, and an update on the location and number of publicly funded PET scanners and cyclotrons across Canada.
Liquid-based techniques for cervical cancer screening
CADTH’s role in informing decision-making.
Fetal fibronectin testing for pre- term labour put to the test in Canada’s arctic
CADTH’s Health Technology Inquiry Service provides insight on treatment protocols.
Eastern Health’s commitment to implementing evidence for the use of off-label and non-formulary medication
A framework for evidence-informed health care.
To P or not to P
Choosing between P-values and confidence intervals.
Emerging issues in genetics technology
A brief look at new genetic tests, and a look at a group that supports the development and implementation of an evidence- based process for evaluating genomic applications.
Research and practice
A list of recent health technology assessment and clinical practice guidelines from across Canada